Bristol-Myers Squibb News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

27.07.17	InvestorsObserver releases covered-call reports for Amazon.com, Bristol-Myers Squibb, Celgene, PayPal Holdings Inc. and Twitter (PR Newswire)
24.07.17	Bristol-Myers Squibb Reports Expanded Approval For Yervoy - Quick Facts (RTTNews)
11.07.17	ARNA Heartened By Phase II Trial, BMY To Face FDA In Nov., Concert Back In Play (RTTNews)
10.07.17	FDA Accepts For Priority Review Bristol-Myers' SNDA For Sprycel For Children (RTTNews)
07.07.17	BMY's Orencia Scores Another FDA Nod, Janssen Ends Deal With CAPR, PBYI On Track (RTTNews)
05.07.17	Bristol-Myers Phase 3 Study Of Opdivo Vs Yervoy Meets Primary Goal (RTTNews)
05.07.17	Breakfast Technical Briefing on Drug Makers Stocks -- Bristol Myers Squibb, Eli Lilly, AstraZeneca, and Sanofi (PR Newswire)
21.06.17	S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017 (PR Newswire)
16.06.17	Bristol-Myers Reports Opdivo Follow-Up Data - Quick Facts (RTTNews)
16.06.17	Bristol-Myers To Sell Manufacturing Facility In Swords, Ireland - Quick Facts (RTTNews)
06.06.17	Novartis, Bristol-Myers To Evaluate Treatments In Metastatic Colorectal Cancer (RTTNews)
03.06.17	Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies (PR Newswire)
02.06.17	Bristol-Myers Reports Opdivo Data, Shows Overall Response Rate Of 26.3% (RTTNews)
02.06.17	Bristol-Myers & Seattle Genetics To Evaluate Combination Of Opdivo And ADCETRIS (RTTNews)
01.06.17	Drug Makers Stocks on Investors' Radar -- AstraZeneca, Bristol-Myers Squibb, Eli Lilly, and Sanofi (PR Newswire)
30.05.17	Array BioPharma, Bristol-Myers Squibb Announce Strategic Collaboration (RTTNews)
30.05.17	Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration (PR Newswire)
19.05.17	EMA Validates Application For Bristol-Myers' Sprycel In Children With CML (RTTNews)
15.05.17	Agilent Announces Expanded Use For PD-L1 IHC 28-8 PharmDx Diagnostic In Europe (RTTNews)
28.04.17	Bristol-Myers: China FDA Oks Daklinza, Sunvepra Combination For HCV (RTTNews)
27.04.17	Bristol-Myers Squibb Co. Reveals 13% Rise In Q1 Bottom Line (RTTNews)
27.04.17	Bristol-Myers Squibb Q1 Profit Rises; Lifts 2017 Profit View (RTTNews)
24.04.17	Drug Makers Stocks Under Scanner -- Bristol-Myers, AstraZeneca, Eli Lilly, and Immune Pharma (PR Newswire)
17.04.17	Bristol-Myers, Nordic Bioscience To Develop Fibrosis Biomarker Technology (RTTNews)
13.04.17	Bristol-Myers To Get $470 Mln Upfront From Licensing Deals With Biogen, Roche (RTTNews)
06.04.17	Global Oncology Market Gains Ground, Driven by Innovative Cancer Treatment Therapies (PR Newswire)
05.04.17	INNL To Be Acquired, ELGX Seeks Funds, Opdivo At FDA Altar Again, NLNK Abuzz (RTTNews)
04.04.17	FDA Nod For TEVA, Cheers For PRTK, SRNE Hits Goal, SNY Launches Kids Toothpaste (RTTNews)
03.04.17	Bristol-Myers Says CheckMate -143 Fails To Meet Primary Endpoint (RTTNews)
03.04.17	Setback For ACOR In Ampyra Suit, EARS Put On Notice, STDY On Steady Rise (RTTNews)
28.03.17	PICI, Bristol-Myers, CRI Collaborate To Accelerate Immuno-Oncology Research (RTTNews)
27.03.17	XENE Loses Face As Acne Trial Flops, NBRV Awaits LEAP Data, Opdivo Scores A Nod (RTTNews)
20.03.17	Bristol-Myers, CytomX Extend Deal To Find Probody Therapeutics To Treat Cancer (RTTNews)
17.03.17	Technical Reports on Drug Makers Stocks -- Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and Immune Pharma (PR Newswire)
22.02.17	Icahn Takes Stake In Bristol-Myers (RTTNews)
21.02.17	Bristol-Myers Plans $2 Bln Accelerated Share Buyback; Names 3 New Directors (RTTNews)
07.02.17	Technical Reports on Drug Makers Stocks -- Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and Immune Pharma (PR Newswire)
26.01.17	Bristol-Myers Squibb Cuts FY17 Adj. EPS View Below Market - Quick Facts (RTTNews)
26.01.17	Bristol-Myers Squibb Co. Bottom Line Advances 64% In Q4 (RTTNews)
20.01.17	Bristol-Myers Squibb Remains Firmly Negative After Initial Decline (RTTNews)
06.01.17	Trade Alerts: Bristol-Myers Squibb, Nordstrom, Netflix, Regions Financial Corporation and Constellation Brands trade ideas that offer returns of 23% or more! (PR Newswire)
06.01.17	Bristol-Myers Squibb To Explore Use Of GeneCentric's Cancer Subtyping Platform (RTTNews)
05.01.17	AEZS Disappoints, EVOK Gets New Lease Of Life, GNMX Calls For Attention (RTTNews)
21.12.16	Bristol-Myers Squibb: Caforio To Succeed Lamberto Andreotti As Chairman (RTTNews)
21.12.16	Bristol-Myers, Calithera Biosciences Announce Clinical Trial Collaboration (RTTNews)
20.12.16	Drug Makers Stocks under Scanner -- Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline (PR Newswire)
20.12.16	Bristol-Myers Signs Exclusive License Deal For PsiOxus Therapeutics' NG-348 (RTTNews)
05.12.16	Bristol-Myers Announces Updated Findings From Phase 1b Trial, CheckMate -012 (RTTNews)
05.12.16	Bristol-Myers Announces Updated Findings From Phase 1b Trial, CheckMate -012 (RTTNews)
01.12.16	InvestorsObserver releases covered-call reports for Netflix, Cisco Systems, Apache Corporation, Bristol-Myers Squibb and Caterpillar Inc. (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

07:45		Novartis-Aktie: EU-Zulassung für Kisqali bei Brustkrebs im Frühstadium
26.11.24		Verluste in New York: Dow Jones legt den Rückwärtsgang ein
26.11.24		Schwache Performance in Europa: Euro STOXX 50 schlussendlich leichter
26.11.24		Börse Zürich: SMI letztendlich in Rot
26.11.24		DAX aktuell: DAX beendet die Dienstagssitzung mit Verlusten
26.11.24		Schwache Performance in Frankfurt: LUS-DAX letztendlich in Rot
26.11.24		S&P 500-Wert Pfizer-Aktie: So viel Verlust wäre bei einem Investment in Pfizer von vor einem Jahr angefallen
26.11.24		Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?

07:45

Novartis-Aktie: EU-Zulassung für Kisqali bei Brustkrebs im Frühstadium

26.11.24

Verluste in New York: Dow Jones legt den Rückwärtsgang ein

26.11.24

Schwache Performance in Europa: Euro STOXX 50 schlussendlich leichter

26.11.24

Börse Zürich: SMI letztendlich in Rot

26.11.24

DAX aktuell: DAX beendet die Dienstagssitzung mit Verlusten

26.11.24

Schwache Performance in Frankfurt: LUS-DAX letztendlich in Rot